Is SQZ or RYLD a better dividend investment in 2026?

SQZ currently yields 459.77% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: SQZ offers higher current income.

What is the dividend yield difference between SQZ and RYLD?

SQZ has a forward dividend yield of 459.77% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 447.63 percentage points.

Home › Compare › SQZ vs RYLD

SQZ vs RYLD: Dividend Comparison 2026

SQZ yields 459.77% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SQZ wins by $32296.78M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SQZ

● Live price

459.77%

Share price

$0.44

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$32296.82M

Annual income

$22,619,113,625.24

Full SQZ calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — SQZ vs RYLD

📍 SQZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SQZ	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SQZ + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SQZ pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SQZ

Annual income on $10K today (after 15% tax)

$39,080.46/yr

After 10yr DRIP, annual income (after tax)

$19,226,246,581.45/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, SQZ beats the other by $19,226,244,382.21/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SQZ + RYLD for your $10,000?

SQZ: 50%RYLD: 50%

100% RYLD50/50100% SQZ

Portfolio after 10yr

$16148.43M

Annual income

$11,309,558,106.29/yr

Blended yield

70.04%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SQZ right now

SQZ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$4.00

+819.5% upside vs current

Range: $4.00 — $4.00

Altman Z

-22.9

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SQZ buys

RYLD buys

No recent congressional trades found for SQZ or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSQZRYLD

Forward yield	459.77% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$32296.82M ✓	$44.5K
Annual income after 10y	$22,619,113,625.24 ✓	$2,587.35
Total dividends collected	$31438.26M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SQZ vs RYLD ($10,000, DRIP)

Year	SQZ Portfolio	SQZ Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$56,677	$45,977.01	$11,914	$1,213.65	+$44.8K → SQZ
2	$304,181	$243,536.41	$14,099	$1,351.30	+$290.1K → SQZ
3	$1,547,006	$1,221,532.43	$16,580	$1,494.55	+$1.53M → SQZ
4	$7,461,354	$5,806,058.08	$19,384	$1,642.61	+$7.44M → SQZ
5	$34,154,829	$26,171,179.52	$22,535	$1,794.70	+$34.13M → SQZ
6	$148,508,521	$111,962,854.47	$26,063	$1,950.00	+$148.48M → SQZ
7	$613,881,121	$454,977,003.60	$29,995	$2,107.69	+$613.85M → SQZ
8	$2,414,527,788	$1,757,674,987.75	$34,361	$2,266.99	+$2414.49M → SQZ
9	$9,044,589,126	$6,461,044,393.43	$39,194	$2,427.12	+$9044.55M → SQZ
10	$32,296,823,990	$22,619,113,625.24	$44,525	$2,587.35	+$32296.78M → SQZ

SQZ vs RYLD: Complete Analysis 2026

SQZ — Stock

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Full SQZ Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this SQZ vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SQZ vs SCHD SQZ vs JEPI SQZ vs O SQZ vs KO SQZ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.